Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hutchmed Share News (HCM)
HCM Share
Price
HCM Share
News
HCM Share
Chat
HCM Share
Trades6
HCM
Live RNS
HCM Share
Charts
HCM Level 2
Console
HCM Live
Share Price
HCM Broker
Ratings
HCM Directors
Deals
HCM Financial
Diary
HCM
Fundamentals
HCM Short
Positions
HCM
Media
HCM Company
Research
HCM Company
Timeline
Share Price Information for Hutchmed (HCM)
Last checked at -
Last checked at 
Intraday Hutchmed Share Chart
Hutchmed News
Hutchmed medicines get renewed, new reimbursement coverage in China
(Sharecast News) - Hutchmed China said on Monday that several of its oncology medicines would remain covered under China's state reimbursement system ...
Hutchmed drugs stay on NRDL; Tazverik added to new insurance list
(Alliance News) - Hutchmed China Ltd on Monday said several of its oncology medicines will continue to be reimbursed under China's national insurance ...
Hutchmed enrols last patient in phase three lung cancer trial
(Sharecast News) - Hutchmed China said in an update on Wednesday that it has completed patient enrollment for its global phase three 'Saffron' trial e...
Hutchmed completes Saffron trial enrolment, results due 2026
(Alliance News) - Hutchmed China Ltd on Wednesday said patient enrolment has been completed for its phase 3 Saffron trial evaluating the combination o...
Hutchmed takes wraps off expanding oncology pipeline
(Sharecast News) - Hutchmed unveiled new details on its expanding oncology pipeline and research strategy, including the launch of its next-generation...
Hutchmed upbeat on preclinical data for novel cancer therapy
(Sharecast News) - Hutchmed China reported preclinical data on Thurdsay, showing strong anti-tumour activity for its novel cancer therapy HMPL-A251, t...
Hutchmed to present new and updated clinical data
(Sharecast News) - Hutchmed China said on Friday that new and updated clinical data from several of its drug candidates would be presented at two majo...
Hutchmed China CFO Cheng is interim CEO as CEO Su takes health leave
(Alliance News) - Hutchmed China Ltd on Tuesday said Chief Executive Officer Weiguo Su will take a leave of absence for health reasons.
Follow the stocks
